Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Psychiatry/Psychology
Disease Category: Memory Loss
Trial Information
A Double-Blind, Placebo-Controlled Trial of Effects of Transdermal Nicotine
on Cognitive Function in Non-smokers With and Without Schizophrenia
Are you or someone you know diagnosed with Schizophrenia? If so, the MGH Schizophrenia Research Program has several opportunities to participate in smoking cessation, memory, concentration, and brain imaging studies.
Requirements for participation:
Ages 18-64
Diagnosed with Schizophrenia
On stable antipsychotic medication for at least one month
Have not smoked for 3 months
Payment for participation up to $200, plus travel reimbursement.
Please contact Priscilla (617) 912-7829 or psinclair1@partners.org for additional information.
Priscilla Sinclair
Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114
Phone: 617-912-7829
EMail: psinclair1@partners.org
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
